Representative before the EPO

Employment test 51 - 200 employees
Company dna dehns ltd
operating since 1920
1358.99
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 43 EP applications Barbara Nicole Rigby has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 15, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12710789

THERAPEUTIC CANCER VACCINE

IPC classification:
A61K 39/00, A61P 35/00
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP11861431

RECOMBINANT ALSV FOR PREVENTING PATHOGENIC VIRAL INFECTION OF PLANT

IPC classification:
A01N 63/00, A01H 5/00, A01H 1/00, C12N 15/83, C12N 15/40, C12N 7/01, C12N 5/10
Applicant:
Iwate University
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
APPLICATION WITHDRAWN
EP12793390

COMPOSITIONS AND METHODS FOR TRANSPORT ACROSS THE BLOOD BRAIN BARRIER

IPC classification:
A61K 48/00, A61K 47/48, A61K 31/7105, A61K 31/7088
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP12730246

ALBUMIN PRODUCTION AND CELL PROLIFERATION

IPC classification:
G06F 19/00, C12N 15/113, A61P 35/00
Agent:
Barbara Nicole Rigby, Dehns Ltd
Agent:
Hoffmann Eitle PartmbB
Status:
EXAMINATION IN PROGRESS
EP12825288

ARTIFICIAL PLACENTA

IPC classification:
A61M 1/16, A61L 27/50, A61L 27/40
Applicant:
McMaster Industry Liaison Office
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
The patent has been granted
EP13179127

Modified plant defensin

IPC classification:
C12N 15/63, C12N 15/62, C12N 15/29, C07K 19/00, C07K 14/415, C07K 2/00
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14154684

Saxagliptin derivatives

IPC classification:
C07D 403/12, A61P 3/10
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11874886

USE OF NEU1 SIALIDASE INHIBITORS IN THE TREATMENT OF CANCER

IPC classification:
A61K 31/36, A61K 31/351, A61K 31/215, A61K 31/196, C07D 317/68, C07D 309/30, C07C 233/52, A61P 35/04, A61P 35/00
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP12826933

RSV MUCOSAL VACCINE

IPC classification:
A61K 39/39, A61K 39/25, A61K 39/00, C07K 14/08, C07K 14/00, C07K 7/08, A61P 31/16, A61P 31/00
Applicant:
The University of Tokushima
Agent:
Multiple attorneys, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP12862008

TARGET MOLECULE TO WHICH AMYLOSPHEROID BINDS AND INDUCES MATURE NEURONAL CELL DEATH, METHOD AND SUBSTANCE FOR INHIBITING AMYLOSPHEROID-INDUCED NEURONAL CELL DEATH, AND USES FOR SAID TARGET MOLECULE, METHOD, AND SUBSTANCE

IPC classification:
A61K 45/00, A61K 38/00, A61K 31/7088, G01N 33/50, G01N 33/15, C12Q 1/42, C12N 15/09, C12N 9/16, C07K 14/00, A61P 25/28
Applicant:
TAO Health Life Pharma Co., Ltd
Agent:
Multiple attorneys, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP12852409

DEVELOPMENT OF NOVEL MACROMOLECULE TRANSDUCTION DOMAIN WITH IMPROVED CELL PERMEABILITY AND METHOD FOR USING SAME

IPC classification:
A61K 47/42, C07K 7/08, C07K 7/06
Agent:
Multiple attorneys, Dehns Ltd
Status:
PATENT GRANTED
EP12852406

COMPOSITION FOR PREVENTING, TREATING OR ALLEVIATING ATOPIC DERMATITIS COMPRISING IMMUNOSUPPRESSANT AND TRANSGLUTAMINASE 2 INHIBITOR

IPC classification:
A61K 39/395, A61K 38/13, A61K 31/44, A61P 17/00
Applicant:
Dongguk University Industry-Academic Cooperation Foundation
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13743511

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES CONTAINING TENC1 EXPRESSION OR ACTIVITY SUPPRESSOR

IPC classification:
A61K 38/17, A61K 38/16, A61K 31/7105, A61P 3/10
Applicant:
Postech Academy-Industry Foundation
Agent:
Multiple attorneys, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP14168608

Combined measles-malaria vaccine

IPC classification:
A61K 39/295, A61K 39/165, A61K 38/15, A61K 35/76, C12N 15/09, C12N 7/08, C12N 7/04, C12N 7/02, C12N 7/01, A61P 33/06
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP14176353

An improved process for the preparation of Rupatadine Fumarate

IPC classification:
A61K 31/4545, C07D 401/14, C07D 213/30, A61P 37/08, A61P 11/02
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13791642

PROTEIN AND PROTEIN CONJUGATE FOR DIABETES TREATMENT, AND APPLICATIONS THEREOF

IPC classification:
A61K 38/30, A61K 38/26, A61K 38/16, C12N 15/62, C07K 19/00, C07K 14/605, C07K 14/595, C07K 14/545, A61P 3/10
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
Examination is in progress
EP13791047

RECOMBINANT AUTO-ACTIVATING PROTEASE PRECURSORS

IPC classification:
A61K 38/48
Applicant:
Saint Louis University
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13806248

ANTI-INFLAMMATORY PROTEINS AND PEPTIDES AND METHODS OF PREPARATION AND USE THEREOF

IPC classification:
A61K 38/17, A61K 38/08, A61K 35/64, A61P 29/00
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13859121

CH3 DOMAIN VARIANT PAIR INDUCING FORMATION OF HETERODIMER OF HEAVY CHAIN CONSTANT REGION OF ANTIBODY AT HIGH EFFICIENCY, METHOD FOR PREPARING SAME, AND USE THEREOF

IPC classification:
A61K 39/395, C12N 15/13, C07K 16/46, C07K 16/18
Applicant:
Ajou University Industry-Academic Cooperation Foundation
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13870699

NOVEL PEPTIDE HAVING COLLAGEN SYNTHESIZING ABILIITY AND USE THEREOF

IPC classification:
A61K 38/17, A61K 38/16, A61K 8/64, A61Q 19/08, A61Q 19/00, A61P 17/00
Applicant:
Novacell Technology Inc.
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
The patent has been granted
EP14751989

A METHOD OF TREATING OBESITY

IPC classification:
A61K 39/395, A61K 31/7088, A61P 3/04, A61P 3/00, A61K 31/505
Applicant:
McMaster University
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
APPLICATION WITHDRAWN
EP14721927

CCL22 AND CCL17 CANCER BIOMARKERS

IPC classification:
G01N 33/574, G01N 33/50
Applicant:
Cancer Research Technology Ltd
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP13881974

EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY

IPC classification:
A61P 35/00, A61K 51/10, A61K 39/44, A61K 39/395, C12N 15/13, C07K 16/08
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
EXAMINATION REQUESTED
EP13875242

PROTEIN TRANSDUCTION DOMAIN BASED ON GOLD NANOPARTICLE-APTAMER CONJUGATE AND METHOD FOR PRODUCING SAME

IPC classification:
C12N 15/115, A61K 47/48, A61K 9/14, A61K 9/16
Applicant:
Chung-Ang University Industry-Academy Cooperation
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
EXAMINATION REQUESTED
EP14807339

MDCK-DERIVED CELL STRAIN SUSPENSION-CULTURED IN PROTEIN-FREE MEDIUM AND METHOD FOR PROLIFERATING VIRUS USING CELL STRAIN

IPC classification:
A61K 39/12, C12N 5/02, C12N 5/071, C12N 5/10
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
The patent has been granted
EP14759311

INDOLE-3-CARBINOL DERIVATIVES

IPC classification:
A61P 35/00, A61K 31/404, C07D 209/12
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP14851420

NOVEL HETEROCYCLIC COMPOUNDS

IPC classification:
C07C 229/14, C07D 217/04, C07D 215/20, C07D 215/06, A61K 31/519, A61K 31/4985, A61K 31/472, A61K 31/47, A61K 31/439, A61K 31/437, A61K 31/4365, A61K 31/4162, A61K 31/407, A61K 31/404, C07D 491/08
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
EXAMINATION REQUESTED
EP12702318

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER

IPC classification:
A61K 39/00, A61P 35/00, A61K 39/04, A61K 35/74, C12N 1/20
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
No opposition filed within time limit
EP14875376

EXPRESSION VECTOR HAVING IMPROVED ABILITY TO EXPRESS GENE

IPC classification:
C12N 15/85, C12N 15/69, C12N 15/67
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
EXAMINATION REQUESTED
EP15789069

MICROORGANISM HAVING IMPROVED L-LYSINE PRODUCTIVITY AND METHOD FOR PRODUCING L-LYSINE USING SAME

IPC classification:
C12R 1/15, C12P 13/08, C12N 1/21
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
EXAMINATION REQUESTED
EP15795999

PD-L1 FUSION PROTEIN AND USE THEREOF

IPC classification:
A61P 37/02, A61K 39/395, A61K 38/17, C12N 15/62, C07K 19/00
Applicant:
Postech Academy-Industry Foundation
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
EXAMINATION REQUESTED
EP15796520

COMPOSITION FOR TREATING OR PREVENTING METABOLIC DISEASE, CONTAINING, AS ACTIVE INGREDIENT, EXTRACELLULAR VESICLES DERIVED FROM AKKERMANSIA MUCINIPHILA BACTERIA

IPC classification:
A61P 3/10, A61P 3/04, A61K 35/66, A61K 35/74
Agent:
Barbara Nicole Rigby, Dehns Ltd
Agent:
AWA
Status:
EXAMINATION REQUESTED
EP16798376

ANTIVIRAL AGENT COMPRISING RNA OLIGONUCLEOTIDE

IPC classification:
C12N 15/113, A61K 31/713, A61K 48/00
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
Request for examination was made
EP15859435

SYNTHESIS OF NANO AGGREGATE OF CHITOSAN MODIFIED BY SELF-ASSEMBLING PEPTIDE AND APPLICATION THEREOF TO PROTEIN DELIVERY

IPC classification:
A61K 38/00, A61K 47/36, A61K 47/34, A61K 47/42
Applicant:
Tokyo University of Science
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
Request for examination was made
EP15866344

DPP4 IMMUNOADHESIN COMPOSITIONS AND METHODS

IPC classification:
A61K 31/14, A61K 39/42, A61K 39/215, C12P 21/02, C12N 15/63, C07K 16/10, C07K 19/00, C07K 14/165, C07K 14/47
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
Request for examination was made
EP15870320

METHODS FOR CONFERRING OR ENHANCING HERBICIDE RESISTANCE ON PLANTS AND/OR ALGA WITH PROTOPORPHYRINOGEN OXIDASE VARIANTS

IPC classification:
C12N 5/10, A01H 5/00, C12N 15/09
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
Request for examination was made
EP17183041

USE OF AKT PHOSPHORYLATION AS A BIOMARKER FOR PROGNOSING NEURODEGENERATIVE DISEASES AND TREATING SAME

IPC classification:
A61K 39/00
Applicant:
Yeda Research and Development Co. Ltd.
Applicant:
University Medical Center Hamburg-Eppendorf (Universitätsklinikum Hamburg-Eppendorf (UKE))
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
Request for examination was made
EP16776829

ASPERGILLUS NIGER

IPC classification:
A01N 63/04, C12N 1/14
Applicant:
Industry Foundation of Chonnam National University
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
Request for examination was made
EP16803815

FUNCTIONAL CELL SHEET USING ELECTRICALLY ACTIVATED CONDUCTIVE POLYMER, AND METHOD OF PRODUCING SAME

IPC classification:
C12N 5/00, A61L 27/00
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
Request for examination was made
EP16807859

MODIFIED INTERLEUKIN-7 PROTEIN AND USES THEREOF

IPC classification:
A61K 38/20, C07K 19/00, C07K 14/54
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
Request for examination was made
EP16814724

CELL-FREE DNA CAPTURE PLATFORM USING CONDUCTIVE POLYMER AND USE OF THE PLATFORM

IPC classification:
C08L 101/12, C08L 79/04, C12Q 1/68, C12N 15/10
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
Request for examination was made
EP16830784

NOVEL COMPOUND HAVING BLT INHIBITORY ACTIVITY AND COMPOSITION, FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, COMPRISING SAME AS ACTIVE INGREDIENT

IPC classification:
A61K 31/435, A61K 31/5375, A61K 31/4965, C07D 211/06, C07D 265/30, C07D 241/04, C07C 233/07
Applicant:
Korea University Research and Business Foundation
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
Request for examination was made
EP16830783

NOVEL COMPOUND HAVING BLT INHIBITORY ACTIVITY AND COMPOSITION, FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, COMPRISING SAME AS ACTIVE INGREDIENT

IPC classification:
A61K 31/435, A61K 31/5375, A61K 31/4965, C07D 211/06, C07D 265/30, C07D 241/04, C07C 233/07
Applicant:
Korea University Research and Business Foundation
Agent:
Barbara Nicole Rigby, Dehns Ltd
Status:
Request for examination was made

Please Sign in to use this feature